Safety of In-hospital Parenteral Antiosteoporosis Therapy Following a Hip Fracture: A Retrospective Cohort
In-hospital parenteral osteoporosis treatment was rarely associated with fever or renal function impairment but was associated with hypocalcemia. Posttreatment hypocalcemia risk did not vary significantly between patients receiving ZOL or Dmab.
Authors
- Uri Yoel (ORCID: https://orcid.org/0000-0003-3805-3565)
- Anat Tsur (ORCID: https://orcid.org/0000-0001-8573-4705)
- Lior Baraf (ORCID: https://orcid.org/0000-0001-8714-1858)
- Merav Fraenkel (ORCID: https://orcid.org/0000-0002-9039-5565)
- Yan Press (ORCID: https://orcid.org/0000-0001-9245-4891)
- Alaa Abu-Jwead
- Adi Goldabart
- David L Fisher
Institutions
- Ben-Gurion University of the Negev (IL)
- Hebrew University of Jerusalem (IL)
- Soroka Medical Center (IL)
- University Medical Center (US)
- Clalit Health Services (IL)
Publication Details
- Journal
- Journal of the Endocrine Society
- Published
- 2024-09-26
- DOI
- https://doi.org/10.1210/jendso/bvae172
- Citations
- 2
- Primary Topic
- Bone health and osteoporosis research
- Type
- article
- Field-Weighted Citation Impact
- 0.96